The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. - Wikidata - wikimedia - TriplyDB

The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.

The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.

http://www.wikidata.org/entity/Q34806020

about

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer Use of miRNAs as biomarkers in sepsis The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis Deregulation of miR-193b affects the growth of colon cancer cells via transforming growth factor-β and regulation of the SMAD3 pathway Computational prediction of disease microRNAs in domestic animals MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.Site-specific associations between miRNA expression and survival in colorectal cancer cases.Biomarkers of colorectal cancer: recent advances and future challenges.MicroRNA dysregulation as a prognostic biomarker in colorectal cancer Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.Molecular profiling in colorectal cancer: current state of play and future directions

P2860

Q26748881-7B458E54-4F8E-4072-BEE2-9B7741782583 Q26775610-52D8E4AA-5056-4A76-B9E7-FF61CE517473 Q26801909-50D50A11-8246-4564-8369-3D68E08A8E82 Q26825022-CD7B1A96-09AB-4C89-87C8-EC530E0127FA Q26996424-D263B9FD-41E5-477A-AFE1-C6B86A4431B0 Q28545216-4935FE45-AB4D-45DE-BCA1-11A5BCFCE5CE Q33598197-2E1B5D12-17B3-4483-936B-8A944BF04F8A Q33881021-33119622-AEBD-469C-8881-13A1C52B712B Q33962495-2AC8117A-9A5E-4B62-B43A-2154193690F6 Q36057174-48B8CE47-BD66-48D8-A04D-70EE381CE824 Q37026076-B87A0009-E0C8-48D8-B44C-50BE42BA6BA0 Q37645004-35ED3197-B5F2-48A3-8BBC-B8ED1539DB89 Q38259770-B7BECFB4-87FF-4850-B33B-EBDE90D001DD Q38262497-86D07DC6-13DC-482D-8CA0-CBCF8218D0FC Q38580491-5060F2B9-CD45-49A5-BB82-39DF644F7B31 Q38959272-2B3E65D2-606E-455A-B362-FEDCF7CA9940 Q41084362-05DE1676-0D3D-45EF-9E67-D512CB9975BD Q53217902-BF2B7CBA-4C1E-4EB0-8D57-75204E3FA1F7 Q54687516-B627026C-3587-4649-BCAE-B5B5567322B4

P2860

The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse.

http://www.wikidata.org/entity/Q34806020

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The functional significance of ...... for predicting early relapse.

@ast

The functional significance of ...... for predicting early relapse.

@en

The functional significance of ...... for predicting early relapse.

@nl

type

label

The functional significance of ...... for predicting early relapse.

@ast

The functional significance of ...... for predicting early relapse.

@en

The functional significance of ...... for predicting early relapse.

@nl

prefLabel

The functional significance of ...... for predicting early relapse.

@ast

The functional significance of ...... for predicting early relapse.

@en

The functional significance of ...... for predicting early relapse.

@nl

P1433

Q34806020-8DBFE2E3-C1ED-4E4E-89E7-6A2C1527D994

P1476

Q34806020-C64C1454-A34B-42EE-98B3-EB97B9F56009

P2093

Q34806020-307904E7-C7A0-4E47-8BF7-487934BC7992

Q34806020-340D2E73-7B19-4BE9-B450-66CBEB4F7407

Q34806020-6F22D610-EA4F-45A3-9617-35C3E0EE5DE0

Q34806020-7BD11137-B525-45F2-95D3-7D1600DE29A0

Q34806020-9B93B59A-53F4-4167-B0D5-81B657BF351E

Q34806020-C6858356-95D9-468E-91C9-E452EE6E02F8

P2860

Q34806020-030140B9-B9E3-4252-9197-794D0E660C6A

Q34806020-06F07D9D-2210-4DD2-ADF1-6AE179D13696

Q34806020-081FF453-093F-49E2-B101-4FAD7B4F2371

Q34806020-0B92F375-0299-4DFE-93D6-471957403FC9

Q34806020-1CBD4A9F-F472-4D67-B09A-E4D167AEAD71

Q34806020-240D803E-6B9E-40CF-AAD7-A79EEACB86D3

Q34806020-25994EAA-E186-40F6-8E55-9A532083BE3C

Q34806020-28A0E112-473E-4B21-84F3-47AB098B355D

Q34806020-2EF84163-CBF0-4742-B3CF-82258E566787

Q34806020-3BCFAB8C-B4ED-4237-990E-DD929F913CCA

P304

Q34806020-5223CA4E-14AD-4280-94D1-4BF52A096F3D

P31

Q34806020-40C14BB1-BC84-4D60-997F-F05270BABC1C

P356

Q34806020-AB554881-3BCC-4ECE-81B6-D36453F23122

P407

Q34806020-C74B3350-E418-4992-BAF4-AB58ECD46B4A

P433

Q34806020-E0B8EF89-4CAE-42A7-959A-6B6FF762E7E9

P478

Q34806020-A174F71A-2599-4411-A896-5E856C970022

P50

Q34806020-522027DA-7C1F-424C-9948-F7D31F909872

P577

Q34806020-0918F39B-B5E6-47C0-899D-F296001D908B

P5875

Q34806020-AAF3AB6E-349F-4C37-AA2D-1F53CA1757F2

P698

Q34806020-F7A2ECC6-6695-4508-8F80-40A9C06AE339

P921

Q34806020-052E5F59-2446-479D-A5F9-12F090B86874

Q34806020-1C940E28-4516-4664-AA3E-AA91EA821C69

Q34806020-2D98697E-BD21-4E15-977D-B5DA80102E86

P932

Q34806020-7338B18D-BD78-4F6D-8871-6DD06E51E916

P356

JOURNAL.PONE.0066842

P1433

P1476

The functional significance of ...... r for predicting early relapse

@en

P2093

Ching-Wen Huang

http://www.w3.org/2001/XMLSchema#string

Hsiang-Lin Tsai

http://www.w3.org/2001/XMLSchema#string

I-Ping Yang

http://www.w3.org/2001/XMLSchema#string

Jaw-Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Ming-Yii Huang

http://www.w3.org/2001/XMLSchema#string

Suh-Hang Hank Juo

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

MicroRNA gene expression deregulation in human breast cancer

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications

Negative regulation of the tumor suppressor p53 gene by microRNAs.

P304

e66842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0066842

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248385573

http://www.w3.org/2001/XMLSchema#string

P698

23840538

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3696003

http://www.w3.org/2001/XMLSchema#string